A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT06150560

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose supportive care
Phase
Phase 3
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06150560
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06150560. Randomized; double masking; primary purpose supportive care. Start 2024-04-01 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Acronym
VALUE
Condition
Coarctation of Aorta
Intervention (Drug)
Losartan
Intervention (Drug)
Amlodipine
Intervention (Drug)
Placebo
Lead sponsor
Mayo Clinic (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct06150560
Content hash
eda64a17359840687359cddce3ff3d4773f620972fbe509b7c9dfaec3164c75d